Regenerative Medical Technology Group Inc
OTC:RMTG

Watchlist Manager
Regenerative Medical Technology Group Inc Logo
Regenerative Medical Technology Group Inc
OTC:RMTG
Watchlist
Price: 0.0372 USD
Market Cap: $488.8k

Operating Margin

6.9%
Current
Improving
by 40.2%
vs 3-y average of -33.3%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
6.9%
=
Operating Income
$265.5k
/
Revenue
$3.9m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
6.9%
=
Operating Income
$265.5k
/
Revenue
$3.9m

Peer Comparison

Country Company Market Cap Operating
Margin
US
Regenerative Medical Technology Group Inc
OTC:RMTG
466.5k USD
Loading...
CH
Avolta AG
SIX:AVOL
6.8B CHF
Loading...
IN
Lenskart Solutions Ltd
NSE:LENSKART
753.4B INR
Loading...
DE
Fielmann Group AG
XMUN:FIE
3.5B EUR
Loading...
IN
Brainbees Solutions Ltd
NSE:FIRSTCRY
130.6B INR
Loading...
ID
MAP Aktif Adiperkasa Tbk PT
IDX:MAPA
18.8T IDR
Loading...
IN
Thangamayil Jewellery Ltd
BSE:533158
93.5B INR
Loading...
IN
P N Gadgil Jewellers Ltd
NSE:PNGJL
75.6B INR
Loading...
SE
Haypp Group AB (publ)
STO:HAYPP
3.6B SEK
Loading...
HK
Eternal Beauty Holdings Ltd
HKEX:6883
2.8B HKD
Loading...
JP
Intermestic Inc
TSE:262A
54.3B JPY
Loading...

Market Distribution

In line with most companies in the United States of America
Percentile
52nd
Based on 14 112 companies
52nd percentile
6.9%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Regenerative Medical Technology Group Inc
Glance View

Market Cap
488.8k USD
Industry
Retail

Meso Numismatics, Inc. engages in the provision of regenerative stem cell therapy. The company is headquartered in Boca Raton, Florida. The company went IPO on 2001-12-28. The firm through its subsidiary, Global Stem Cells Group (GSGC), the Company specializes in manufacturing clinical products, cutting edge stem cell research, patient applications, and physical training. The company is engaged in regenerative medicine global research, clinical applications, world class products, lab and clinic equipment, and physician training. Its services include certified training courses for physicians, manufacturing and sales of equipment and supplies, research and development of clinical protocols, regenerative medicine clinics for patients, regenerative medicine practitioners’ network, and turnkey stem cell processing center solutions. The firm with ISSCA (International Society for Stem Cell Application) provides comprehensive physician training and certification programs that medical professionals are equipped with the latest advancements and techniques.

RMTG Intrinsic Value
0.1717 USD
Undervaluation 78%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
6.9%
=
Operating Income
$265.5k
/
Revenue
$3.9m
What is Regenerative Medical Technology Group Inc's current Operating Margin?

The current Operating Margin for Regenerative Medical Technology Group Inc is 6.9%, which is above its 3-year median of -33.3%.

How has Operating Margin changed over time?

Over the last 3 years, Regenerative Medical Technology Group Inc’s Operating Margin has increased from -975.3% to 6.9%. During this period, it reached a low of -975.3% on May 30, 2022 and a high of 8.2% on Mar 31, 2025.

Back to Top